Huge Sertoli-Leydig cell tumor: a rare case report

Sertoli-Leydig cell tumors (SLCTs), constitute less than 0.5% of all ovarian tumors. SLCT are rare after menopause (less than10%), 75 years, unmarried, postmenopausal since 30 years, presented with complaints of abdominal swelling. On examination, abdominal mass of 36 weeks, hard, immobile felt. Ultrasonography of abdomen showed lobulated solid cystic lesion of size 22 x 15 x 27 cms with bilateral ovaries not separately visualized. Moderate free fluid in the abdomen, suggestive of malignant neoplastic etiology. CECT Abdomen + pelvis suggestive of primary ovarian malignancy with omental deposits and pelvic adenopathy. CA 125- 415.1 Patient underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy with huge tumour mass excision (weight 5.25 kg) with umbilical hernia repair. Frozen section suggestive of a huge mass of 30 x 20 x 15 cm, multilobulated, yellowish white tan in colour, solid-cystic in consistency, seen arising from right ovary. Omentum appears normal. Histopathology report s/o- Moderately differentiated Sertoli Leydig cell tumor. Reporting the first, this huge, in this age group with atypical presentation.

Metastatic rhabdomyosarcomatous elements, mimicking a primary sarcoma, in the omentum, from a poorly differentiated ovarian Sertoli-Leydig cell tumor in a young girl: An unusual presentation with a literature review.

Sertoli-Leydig cell tumors (SLCTs) of the ovary with mesenchymal heterologous elements are uncommon. Only few such cases have been documented, showing presence of only mesenchymal heterologous elements at the metastatic site. We report an unusual case in a young girl who presented with an omental mass that was consistent with histopathological features of a high-grade sarcoma, with prominent rhabdomyoblastic differentiation of the embryonal type. The sections from her ovarian mass for which she was operated a year back displayed features of a poorly differentiated SLCT with heterologous elements, including focal rhabdomyoblastic differentiation. This is one of the rare cases, to the best of our knowledge, where only rhabomyosarcomatous elements were identified at the metastatic site, mimicking a primary abdominal rhabdomyosarcoma, in a case of an ovarian SLCT. Further, this case reinforces the presence of rhabdomyosarcomatous elements in an ovarian SLCT to be associated with an aggressive disease course.

Tumor de células de Leydig, presentación con pubertad precoz

Objetivos: Presentar un caso de pubertad precoz secundaria a tumor de células de Leydig. Caso Clínico: Paciente preescolar masculino de 5 años, quien fue referido por presentar aparición de vello púbico, aumento de tamaño del pene, piel oleosa y crecimiento acelerado para la edad, sin antecedentes de traumatismo craneal o procesos infecciosos cerebrales. Al examen físico: peso 22,7kg y talla 117,2 cm, ambos en el percentil 97, masas musculares evidentes en tórax y miembros superiores, vello púbico tanner II, pene de 6cm de longitud, con volumen testicular de 4 mL el derecho y de 3 mL el izquierdo, observándose mucho adelanto de caracteres sexuales secundarios para el volumen testicular. Los estudios de laboratorio revelaron valores elevados de andrógenos: testosterona libre: 237 ng/dL, 17OHP: 3.7 ng/mL, prueba de GnRH con respuesta prepuberal, no plana (pico de LH: 3,4 y de FSH: 1,8 ng/mL), prueba de estimulación con ACTH reporta 17OHP basal 5.3 y postestímulo 6 ng/mL, TSH: 2,1 mUI/mL, T4L: 1,10 ng/dL. Edad ósea de 10 años, relación EO/EC de 1.9, predicción de talla final de 157 cm, con potencial genético de talla de 169,7. Se planteó Pubertad Precoz Periférica (HAC hiperplasia adonal congénita vs. Gonadal) que desencadenó una pubertad verdadera. Se indicó tratamiento con Triptorelina e Hidrocortisona a dosis habituales por kg de peso. En su evolución clínica, a pesar del tratamiento y mostrando normalización de niveles de 17OHP (1.4 ng/mL) y adecuada supresión del eje Hipotálamo-Hipófisis-Gónada, continuó progresión de caracteres sexuales secundarios, aumentando la asimetría testicular VD: 8mL y VI: 6mL, pene de 9 cm y la velocidad de crecimiento de 12 cm/año. Nuevos niveles de testosterona muy elevados (770 ng/dL). TAC de abdomen normal y ultrasonido testicular reportó LOE sólido en testículo derecho. Marcadores tumorales normales, excepto ligera elevación de Gonadotropina Coriónica. Se realiza orquidectomía derecha y ligadura alta de cordón. El estudio anatomopatológico reportó tumor de células de Leydig sin signos de malignidad. Conclusiones: Los tumores testiculares son muy raros en niños (1 a 2%) y aproximadamente el 1 a 3% de éstos, corresponden a los de células de Leydig, que se presentan con desarrollo somático precoz y virilización progresiva, siendo una causa de precocidad puberal.

Objectives: To report a case of precocious puberty due to a Leydig cell tumor. Clinical Case: A 5 years old male patient, with pubic hair, penis enlargement, oiliness of skin and accelerated growth was referred. There was no previous cranial traumatism or cerebral disease. Physical examination: weight 22,7 kg, height 117,2 cm, both over 97th percentile for age, muscular development in thorax and upper extremities, pubic hair (Tanner II), penis of 6 cm of longitude, volume of right testicle 4 mL and left 3 mL. More signs of pubertal development than would be expected for the size of the testis were evident. The laboratory analysis showed elevated levels of androgens: free testosterone: 237 ng/dL, 17OHP: 3,7 and 5,3 ng/mL basally and 6 ng/mL post stimulation with ACTH, slight response to the GnRH stimulation test (LH peak: 3,4 and FSH peak: 1,8 ng/mL), normal levels of TSH and FT4. Bone age of 10 years, BA/CA of 1,9, predicted adult height of 157 and target height of 169,7 cm. The diagnostic of peripheral precocious puberty (congenital adrenal hyperplasia vs gonadal tumor) that triggered a central precocity was suggested. Treatment with Triptorelin and Hydrocortisone was initiated in usual doses. With this therapy, the 17OHP levels were normal and a suppression of LH and FSH were obtained. Nevertheless, the boy showed progression of the pubertal development, right testicle of 8 mL, left of 6 mL, penis of 9 cm and growth velocity of 12 cm/ year. Testosterone levels were higher (770 ng/dL). Abdominal computerized axial tomography was normal and the testicular ultrasonography disclosed a solid tumor in the right testicle. Tumor markers were normal. Surgical removal of the right testicle was done. The histopathology study revealed a Leydig cell tumor without malignancy signs. Conclusions: Testicular tumors are rare in children (1 a 2%) and 1-3% of them are Leydig cell tumors. They may cause incomplete precocious puberty with somatic development and progressive virilization.

Two Cases of Sertoli-Leydig Cell Tumor without Masculinized Symptom / 대한산부인과학회잡지

Sertoli-Leydig cell tumor is an uncommon tumor that may manifest itself by a characteri-stic virilization symptom. It is a rare gonadal tumor of sex-cord type, representing only 0.1~0.5% of all primary ovarian neoplasm. These tumors are the most common virilizing tumors in women of reproductive age. However, only one-third of patients develop masculinization. We have seen two cases of Sertoli-Leydig cell tumors without the virilizing symptom. These two cases have been confirmed by permanent tissue biopsies and have been presented in a 32-year old female who has had only amenorrhea and in a 56-year old postmenopausal female who has not manifested virilizing symptom. These cases are presented with brief review of the literature.